InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OCULAR THERAPEUTIX, INC

OCUL Clue Score42
United States Fiscal year ends December CIK 0001393434
$7.54 +0.40% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.54 −32.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.9Operating income−43.3Net income−44.7Fiscal year 2017Revenue1.9 +1.9%Operating income−61.9Net income−63.4Fiscal year 2018Revenue2.0 +3.5%Operating income−59.1Net income−60.0Fiscal year 2019Revenue4.2 +112.4%Operating income−85.8Net income−86.4EPS, diluted−1.91Fiscal year 2020Revenue17.4 +311.7%Operating income−62.8Net income−155.6EPS, diluted−2.56Fiscal year 2021Revenue43.5 +150.1%Operating income−78.0Net income−6.6EPS, diluted−0.98Fiscal year 2022Revenue51.5 +18.3%Operating income−78.7Net income−71.0EPS, diluted−0.97Fiscal year 2023Revenue58.4 +13.5%Operating income−82.4Net income−80.7EPS, diluted−1.02Fiscal year 2024Revenue63.7 +9.0%Operating income−171.8Net income−193.5EPS, diluted−1.22Fiscal year 2025Revenue52.0 −18.5%Operating income−270.0Net income−265.9EPS, diluted−1.42
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.9 1.9 2.0 4.2 17.4 43.5 51.5 58.4 63.7 52.0
Growth +1.9% +3.5% +112.4% +311.7% +150.1% +18.3% +13.5% +9.0% −18.5%
Operating income −43.3 −61.9 −59.1 −85.8 −62.8 −78.0 −78.7 −82.4 −171.8 −270.0
Net income −44.7 −63.4 −60.0 −86.4 −155.6 −6.6 −71.0 −80.7 −193.5 −265.9
Growth
EPS, diluted n/a n/a n/a −1.91 −2.56 −0.98 −0.97 −1.02 −1.22 −1.42

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−2,296.0%Net margin−2,369.0%Free cash flow margin−1,903.6%Fiscal year 2017Operating margin−3,220.1%Net margin−3,296.2%Free cash flow margin−3,053.8%Fiscal year 2018Operating margin−2,970.8%Net margin−3,014.0%Free cash flow margin−2,568.6%Fiscal year 2019Operating margin−2,029.9%Net margin−2,043.3%Free cash flow margin−1,888.2%Fiscal year 2020Operating margin−361.1%Net margin−894.3%Free cash flow margin−312.6%Fiscal year 2021Operating margin−179.3%Net margin−15.1%Free cash flow margin−153.4%Fiscal year 2022Operating margin−152.7%Net margin−138.0%Free cash flow margin−123.0%Fiscal year 2023Operating margin−141.0%Net margin−138.1%Free cash flow margin−130.6%Fiscal year 2024Operating margin−269.6%Net margin−303.7%Free cash flow margin−213.4%Fiscal year 2025Operating margin−519.8%Net margin−511.9%Free cash flow margin−417.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −2,296.0% −3,220.1% −2,970.8% −2,029.9% −361.1% −179.3% −152.7% −141.0% −269.6% −519.8%
Net margin −2,369.0% −3,296.2% −3,014.0% −2,043.3% −894.3% −15.1% −138.0% −138.1% −303.7% −511.9%
Free cash flow margin −1,903.6% −3,053.8% −2,568.6% −1,888.2% −312.6% −153.4% −123.0% −130.6% −213.4% −417.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−34.0Capital expenditure−1.9Free cash flow−35.9Fiscal year 2017Operating cash flow−50.5Capital expenditure−8.3Free cash flow−58.7Fiscal year 2018Operating cash flow−49.2Capital expenditure−1.9Free cash flow−51.1Fiscal year 2019Operating cash flow−77.6Capital expenditure−2.2Free cash flow−79.8Fiscal year 2020Operating cash flow−53.6Capital expenditure−0.8Free cash flow−54.4Fiscal year 2021Operating cash flow−65.6Capital expenditure−1.2Free cash flow−66.7Fiscal year 2022Operating cash flow−59.6Capital expenditure−3.7Free cash flow−63.3Fiscal year 2023Operating cash flow−70.2Capital expenditure−6.1Free cash flow−76.3Fiscal year 2024Operating cash flow−134.7Capital expenditure−1.3Free cash flow−136.0Fiscal year 2025Operating cash flow−204.9Capital expenditure−12.0Free cash flow−216.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −34.0 −50.5 −49.2 −77.6 −53.6 −65.6 −59.6 −70.2 −134.7 −204.9
Capital expenditure −1.9 −8.3 −1.9 −2.2 −0.8 −1.2 −3.7 −6.1 −1.3 −12.0
Free cash flow −35.9 −58.7 −51.1 −79.8 −54.4 −66.7 −63.3 −76.3 −136.0 −216.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash32.9Shareholders’ equity52.0Fiscal year 2017Cash41.5Shareholders’ equity26.1Fiscal year 2018Cash54.1Shareholders’ equity35.9Fiscal year 2019Cash54.4Shareholders’ equity−3.6Fiscal year 2020Cash228.1Shareholders’ equity76.1Fiscal year 2021Cash164.2Shareholders’ equity88.0Fiscal year 2022Cash102.3Shareholders’ equity35.4Fiscal year 2023Cash195.8Shareholders’ equity91.1Fiscal year 2024Cash392.1Shareholders’ equity315.3Fiscal year 2025Cash737.1Shareholders’ equity654.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 32.9 41.5 54.1 54.4 228.1 164.2 102.3 195.8 392.1 737.1
Shareholders’ equity 52.0 26.1 35.9 −3.6 76.1 88.0 35.4 91.1 315.3 654.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1.9 1.9 2.0 4.2 17.4 43.5 51.5 58.4 63.7 52.0
Growth +1.9% +3.5% +112.4% +311.7% +150.1% +18.3% +13.5% +9.0% −18.5%
n/a 0.5 0.5 2.3 2.1 4.4 4.5 5.3 5.6 6.6
27.1 30.9 36.9 41.1 28.7 50.1 53.5 61.1 127.6 197.1
11.0 15.5 18.8 22.1 22.9 31.9 32.2 33.9 60.7 64.4
−43.3 −61.9 −59.1 −85.8 −62.8 −78.0 −78.7 −82.4 −171.8 −270.0
Growth
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−44.7 −63.4 −60.0 −86.4 −155.6 −6.6 −71.0 −80.7 −193.5 −265.9
Growth
Per share
n/a n/a n/a −1.91 −2.56 −0.09 −0.92 −1.01 −1.22 −1.42
n/a n/a n/a −1.91 −2.56 −0.98 −0.97 −1.02 −1.22 −1.42
Growth
n/a n/a n/a 45.3 60.8 76.4 76.9 79.8 158.3 187.2
n/a n/a n/a 45.3 60.8 82.2 82.6 85.6 158.3 187.2
Growth +34.2% +35.2% +0.6% +3.6% +84.9% +18.3%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 24.4% a year over five years.
  • Operating margin is down 158.6 points on five years ago, at -519.8%.
  • A net loss in 10 of 10 years on file.